Espranor (buprenorphine): Reviews and patient testimonials
Medication indications
Espranor 2 mg oral lyophilisate
Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment.
Treatment with Espranor oral lyophilisate is intended for use in adults and adolescents aged 15 years or over who have agreed to be treated for addiction.
Espranor 8 mg oral lyophilisate
Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment.
Treatment with Espranor oral lyophilisate is intended for use in adults and adolescents aged 15 years or over who have agreed to be treated for addiction.
Route of administration: Oral
Molecule: buprenorphine
Patients' opinions on Espranor
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.